Shares of Johnson & Johnson JNJ, +1.58% rallied 1.58% to $175.74 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX, -0.13% falling 0.13% to 3,759.89 and Dow Jones Industrial Average DJIA, -0.15% falling 0.15% to 30,483.13. This was the stock’s second consecutive day of gains. Johnson & Johnson closed $10.95 short of its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. RHHVF, +4.76% rose 4.76% to $317.43, Merck & Co. Inc. MRK, +1.28% rose 1.28% to $89.16, and Pfizer Inc. PFE, +2.00% rose 2.00% to $49.07. Trading volume (10.4 M) eclipsed its 50-day average volume of 7.5 M.